NVS relationship map
NVS
Novartis AG
NVSNovartis AG
BBIOBridgeBio Pharma
2°Bayerunlisted
2°Alexionunlisted
2°Bayer Consumer Careunlisted
IOVAIovance Biotherapeutics2°National Cancer Institute (NCI)unlisted
2°National Institutes of Health (NIH)unlisted
2°Boehringer Ingelheim Biopharmaceuticals GmbHunlisted
OLMAOlema Pharmaceuticals2°Black Shadow Therapeuticsunlisted
2°Aurigene Oncologyunlisted
PLRXPliant TherapeuticsVERAVera TherapeuticsSells to →
2°BX Bodyguard Royaltiesunlisted
2°Rocheunlisted
2°Bayerunlisted
2°Yale Universityunlisted
2°Panda Expressunlisted
2°Dairy Queenunlisted
2°Swedish Orphan Biovitrum ABunlisted
2°Otsuka Pharmaceuticalunlisted
2°Royalty Pharma Investments 2019 ICAV (Royalty Pharma)unlisted
2°Akcea Therapeuticsunlisted
2°Rocheunlisted
2°Simcereunlisted
2°Nippon Shinyaku Co., Ltd. (Nippon Shinyaku)unlisted
2°Nippon Shinyakuunlisted
2°Bill & Melinda Gates Foundationunlisted
2°Brigham and Women's Hospital, Inc. (BWH)unlisted
2°BWHunlisted
← Buys from
NVSNovartis AG
2°Bayerunlisted
2°Alexionunlisted
2°Bayer Consumer Careunlisted
2°National Cancer Institute (NCI)unlisted
2°National Institutes of Health (NIH)unlisted
2°Boehringer Ingelheim Biopharmaceuticals GmbHunlisted
2°Black Shadow Therapeuticsunlisted
2°Aurigene Oncologyunlisted
Sells to →
suppliercustomer2°second-degree (Extended)
sector groupThick line = filed share ·Moves · 09:57 ETSources